Metabolism of 6-Chloro-5-cyclohexylindane-1-carboxylic Acid (TAI-284), a New Non-steroidal Anti-inflammatory Agent. I. Absorption, Distribution and Excretion in Rats
- 1 January 1973
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 3 (10), 643-656
- https://doi.org/10.3109/00498257309151588
Abstract
1. In rats, a new non-steroidal anti-inflammatory agent, 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), labelled with 3H, was almost quantitatively absorbed, mainly from the small intestine. Gastric absorption was also demonstrated. 2. The plasma concn. of the orally administered drug reached a peak at 2 h with a half-life of about 7·5 h. The concn. after intravenous injection decreased biphasically with t0·5 values of 20 and 80 min. About half of the plasma radioactivity was the intact drug, of which more than 90% was bound to plasma protein. Plasma metabolites, detected by t.l.c., were the 4′-oxocyclohexyl derivative (I), a mixture of cis-4′- and cis-3′-hydroxycyclohexyl derivatives (IIa and IIb), trans-4′-hydroxycyclohexyl derivative (III) and cis-3′-hydroxycyclohexyl derivative (IV), together with small amounts of unidentified polar metabolites (V and VI). Metabolites IIb and IV are diastereoisomers. 3. TAI-284, administered orally or intravenously, was widely distributed, with high concn. in stomach, duodenum, liver, small intestine, adrenal and kidney, but far less in brain. The concns. in most tissues were lower than the blood level. Distribution of radioactivity in inflamed tissues was also demonstrated. 4. Oral TAI-284 was completely eliminated from the body within 72 h, with 46·3 and 50·2% of the dose being excreted in urine and faeces, respectively. Some portion of the metabolites was excreted in bile to enter into entero-hepatic cycling. 5. TAI-284 accounted for only a few per cent of the radioactivity in excreta. The major urinary and faecal metabolites were V, VI and III, while most of the biliary radioactivity was derived from metabolite VI. 6. After intravenous injection of [3H]TAI-284 to a pregnant rat radioactivity was transferred to foetuses.Keywords
This publication has 11 references indexed in Scilit:
- Metabolism of 6-Chloro-5-cyclohexylindane-1-carboxylic Acid (TAI-284), a New Non-steroidal Anti-inflammatory Agent. III. Species Differences in MetabolismXenobiotica, 1973
- Metabolism of 6-Chloro-5-cyclohexylindane-1-carboxylic Acid (TAI-284), a New Non-steroidal Anti-inflammatory Agent. II. Isolation and Identification of Metabolites in the Perfusate of the Isolated Liver Perfusion in RatsXenobiotica, 1973
- ANTI-INFLAMMATORY, ANALGESIC AND ANTIPYRETIC ACTIVITIES OF 6-CHLORO-5-CYCLOHEXYLINDAN-1-CARBOXYLIC ACID (TAI-284)The Japanese Journal of Pharmacology, 1971
- 6-Chloro-5-cyclohexylindan-l-carboxylic Acid (TAI-284), a New Antiinflammatory AgentCHEMICAL & PHARMACEUTICAL BULLETIN, 1971
- METABOLIC FATE OF 5-ETHOXYCARBONYL-3-MORPHOLINOSYDNONIMINE (SIN-10): 1. ABSORPTION, EXCRETION AND TISSUE DISTRIBUTION IN RATS AND MICEThe Japanese Journal of Pharmacology, 1970
- Indomethacin-induced intestinal lesions in the ratToxicology and Applied Pharmacology, 1970
- Jejunal ulcers produced by indomethacinJournal of Pharmacy and Pharmacology, 1969
- The Effect of Neomycin and Experimental Coprostasis on the Excretion of Simple Phenols in the RatScandinavian Journal of Gastroenterology, 1969
- Tritium and Carbon-14 by Oxygen Flask CombustionPublished by Springer Nature ,1968
- Use of "Granuloma Pouch" Technic in the Study of Antiphlogistic CorticoidsExperimental Biology and Medicine, 1953